Qingyu Zhou, James M Gallo. J Pharm Biomed Anal 2010
Times Cited: 34
Times Cited: 34
Times Cited
Times Co-cited
Similarity
Bioanalytical method for the quantification of sunitinib and its n-desethyl metabolite SU12662 in human plasma by ultra performance liquid chromatography/tandem triple-quadrupole mass spectrometry.
Peter de Bruijn, Stefan Sleijfer, Mei-Ho Lam, Ron H J Mathijssen, Erik A C Wiemer, Walter J Loos. J Pharm Biomed Anal 2010
Peter de Bruijn, Stefan Sleijfer, Mei-Ho Lam, Ron H J Mathijssen, Erik A C Wiemer, Walter J Loos. J Pharm Biomed Anal 2010
41
Quantification of sunitinib in human plasma by high-performance liquid chromatography-tandem mass spectrometry.
Patton Minkin, Ming Zhao, Zhaoyuan Chen, Jan Ouwerkerk, Hans Gelderblom, Sharyn D Baker. J Chromatogr B Analyt Technol Biomed Life Sci 2008
Patton Minkin, Ming Zhao, Zhaoyuan Chen, Jan Ouwerkerk, Hans Gelderblom, Sharyn D Baker. J Chromatogr B Analyt Technol Biomed Life Sci 2008
38
Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry.
A Haouala, B Zanolari, B Rochat, M Montemurro, K Zaman, M A Duchosal, H B Ris, S Leyvraz, N Widmer, L A Decosterd. J Chromatogr B Analyt Technol Biomed Life Sci 2009
A Haouala, B Zanolari, B Rochat, M Montemurro, K Zaman, M A Duchosal, H B Ris, S Leyvraz, N Widmer, L A Decosterd. J Chromatogr B Analyt Technol Biomed Life Sci 2009
38
In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship.
Dirk B Mendel, A Douglas Laird, Xiaohua Xin, Sharianne G Louie, James G Christensen, Guangmin Li, Randall E Schreck, Tinya J Abrams, Theresa J Ngai, Leslie B Lee,[...]. Clin Cancer Res 2003
Dirk B Mendel, A Douglas Laird, Xiaohua Xin, Sharianne G Louie, James G Christensen, Guangmin Li, Randall E Schreck, Tinya J Abrams, Theresa J Ngai, Leslie B Lee,[...]. Clin Cancer Res 2003
32
A routine feasible HPLC analysis for the anti-angiogenic tyrosine kinase inhibitor, sunitinib, and its main metabolite, SU12662, in plasma.
Marie-Christine Etienne-Grimaldi, Nicole Renée, Hassan Izzedine, Gérard Milano. J Chromatogr B Analyt Technol Biomed Life Sci 2009
Marie-Christine Etienne-Grimaldi, Nicole Renée, Hassan Izzedine, Gérard Milano. J Chromatogr B Analyt Technol Biomed Life Sci 2009
36
Simple and selective method for the determination of various tyrosine kinase inhibitors used in the clinical setting by liquid chromatography tandem mass spectrometry.
R Honeywell, K Yarzadah, E Giovannetti, N Losekoot, E F Smit, M Walraven, J S W Lind, C Tibaldi, H M Verheul, G J Peters. J Chromatogr B Analyt Technol Biomed Life Sci 2010
R Honeywell, K Yarzadah, E Giovannetti, N Losekoot, E F Smit, M Walraven, J S W Lind, C Tibaldi, H M Verheul, G J Peters. J Chromatogr B Analyt Technol Biomed Life Sci 2010
32
Development and validation of a liquid chromatography/tandem mass spectrometry procedure for the quantification of sunitinib (SU11248) and its active metabolite, N-desethyl sunitinib (SU12662), in human plasma: application to an explorative study.
Michael Rodamer, Paul W Elsinghorst, Martina Kinzig, Michael Gütschow, Fritz Sörgel. J Chromatogr B Analyt Technol Biomed Life Sci 2011
Michael Rodamer, Paul W Elsinghorst, Martina Kinzig, Michael Gütschow, Fritz Sörgel. J Chromatogr B Analyt Technol Biomed Life Sci 2011
45
Sunitinib LC-MS/MS Assay in Mouse Plasma and Brain Tissue: Application in CNS Distribution Studies.
Rajneet K Oberoi, Rajendar K Mittapalli, James Fisher, William F Elmquist. Chromatographia 2013
Rajneet K Oberoi, Rajendar K Mittapalli, James Fisher, William F Elmquist. Chromatographia 2013
55
Quantitation of SU1 1248, an oral multi-target tyrosine kinase inhibitor, and its metabolite in monkey tissues by liquid chromatograph with tandem mass spectrometry following semi-automated liquid-liquid extraction.
S Barattè, S Sarati, E Frigerio, C A James, C Ye, Q Zhang. J Chromatogr A 2004
S Barattè, S Sarati, E Frigerio, C A James, C Ye, Q Zhang. J Chromatogr A 2004
26
Development and validation of an HPLC-UV-visible method for sunitinib quantification in human plasma.
Benoit Blanchet, Carole Saboureau, Anne Sophie Benichou, Bertrand Billemont, Fabrice Taieb, Stanislas Ropert, Alain Dauphin, François Goldwasser, Michel Tod. Clin Chim Acta 2009
Benoit Blanchet, Carole Saboureau, Anne Sophie Benichou, Bertrand Billemont, Fabrice Taieb, Stanislas Ropert, Alain Dauphin, François Goldwasser, Michel Tod. Clin Chim Acta 2009
26
Simultaneous determination of nine tyrosine kinase inhibitors by 96-well solid-phase extraction and ultra performance LC/MS-MS.
Stéphane Bouchet, Emmanuelle Chauzit, Dominique Ducint, Nadège Castaing, Mireille Canal-Raffin, Nicholas Moore, Karine Titier, Mathieu Molimard. Clin Chim Acta 2011
Stéphane Bouchet, Emmanuelle Chauzit, Dominique Ducint, Nadège Castaing, Mireille Canal-Raffin, Nicholas Moore, Karine Titier, Mathieu Molimard. Clin Chim Acta 2011
26
Determination of sunitinib and its active metabolite N-desethylsunitinib in sweat of a patient.
Nienke A G Lankheet, Christian U Blank, Henk Mallo, Sandra Adriaansz, Hilde Rosing, Jan H M Schellens, Alwin D R Huitema, Jos H Beijnen. J Anal Toxicol 2011
Nienke A G Lankheet, Christian U Blank, Henk Mallo, Sandra Adriaansz, Hilde Rosing, Jan H M Schellens, Alwin D R Huitema, Jos H Beijnen. J Anal Toxicol 2011
32
A validated assay for the simultaneous quantification of six tyrosine kinase inhibitors and two active metabolites in human serum using liquid chromatography coupled with tandem mass spectrometry.
Nielka P van Erp, Djoeke de Wit, Henk-Jan Guchelaar, Hans Gelderblom, Trees J Hessing, Jan den Hartigh. J Chromatogr B Analyt Technol Biomed Life Sci 2013
Nielka P van Erp, Djoeke de Wit, Henk-Jan Guchelaar, Hans Gelderblom, Trees J Hessing, Jan den Hartigh. J Chromatogr B Analyt Technol Biomed Life Sci 2013
23
Molecular basis for sunitinib efficacy and future clinical development.
Sandrine Faivre, George Demetri, William Sargent, Eric Raymond. Nat Rev Drug Discov 2007
Sandrine Faivre, George Demetri, William Sargent, Eric Raymond. Nat Rev Drug Discov 2007
20
Method development and validation for the quantification of dasatinib, erlotinib, gefitinib, imatinib, lapatinib, nilotinib, sorafenib and sunitinib in human plasma by liquid chromatography coupled with tandem mass spectrometry.
N A G Lankheet, M J X Hillebrand, H Rosing, J H M Schellens, J H Beijnen, A D R Huitema. Biomed Chromatogr 2013
N A G Lankheet, M J X Hillebrand, H Rosing, J H M Schellens, J H Beijnen, A D R Huitema. Biomed Chromatogr 2013
20
Development and clinical application of a LC-MS/MS method for simultaneous determination of various tyrosine kinase inhibitors in human plasma.
Lutz Götze, Axel Hegele, Stephan Klaus Metzelder, Harald Renz, Wolfgang Andreas Nockher. Clin Chim Acta 2012
Lutz Götze, Axel Hegele, Stephan Klaus Metzelder, Harald Renz, Wolfgang Andreas Nockher. Clin Chim Acta 2012
20
Simultaneous determination of sunitinib and its two metabolites in plasma of Chinese patients with metastatic renal cell carcinoma by liquid chromatography-tandem mass spectrometry.
Feng Qiu, Weihua Bian, Jun Li, Zhicheng Ge. Biomed Chromatogr 2013
Feng Qiu, Weihua Bian, Jun Li, Zhicheng Ge. Biomed Chromatogr 2013
50
Single- and multiple-dose disposition kinetics of sunitinib malate, a multitargeted receptor tyrosine kinase inhibitor: comparative plasma kinetics in non-clinical species.
Joshua O Haznedar, Shem Patyna, Carlo L Bello, Geoffrey W Peng, William Speed, Xiaoming Yu, Qingling Zhang, Juthamas Sukbuntherng, David J Sweeny, Lida Antonian,[...]. Cancer Chemother Pharmacol 2009
Joshua O Haznedar, Shem Patyna, Carlo L Bello, Geoffrey W Peng, William Speed, Xiaoming Yu, Qingling Zhang, Juthamas Sukbuntherng, David J Sweeny, Lida Antonian,[...]. Cancer Chemother Pharmacol 2009
17
Quantitation of unbound sunitinib and its metabolite N-desethyl sunitinib (SU12662) in human plasma by equilibrium dialysis and liquid chromatography-tandem mass spectrometry: application to a pharmacokinetic study.
Rana Rais, Ming Zhao, Ping He, Linping Xu, John F Deeken, Michelle A Rudek. Biomed Chromatogr 2012
Rana Rais, Ming Zhao, Ping He, Linping Xu, John F Deeken, Michelle A Rudek. Biomed Chromatogr 2012
50
An automated method for the measurement of a range of tyrosine kinase inhibitors in human plasma or serum using turbulent flow liquid chromatography-tandem mass spectrometry.
L Couchman, M Birch, R Ireland, A Corrigan, S Wickramasinghe, D Josephs, J Spicer, R J Flanagan. Anal Bioanal Chem 2012
L Couchman, M Birch, R Ireland, A Corrigan, S Wickramasinghe, D Josephs, J Spicer, R J Flanagan. Anal Bioanal Chem 2012
17
Approval summary: sunitinib for the treatment of imatinib refractory or intolerant gastrointestinal stromal tumors and advanced renal cell carcinoma.
Vicki L Goodman, Edwin P Rock, Ramzi Dagher, Roshni P Ramchandani, Sophia Abraham, Jogarao V S Gobburu, Brian P Booth, S Leigh Verbois, David E Morse, Cheng Yi Liang,[...]. Clin Cancer Res 2007
Vicki L Goodman, Edwin P Rock, Ramzi Dagher, Roshni P Ramchandani, Sophia Abraham, Jogarao V S Gobburu, Brian P Booth, S Leigh Verbois, David E Morse, Cheng Yi Liang,[...]. Clin Cancer Res 2007
14
Sunitinib malate for the treatment of metastatic renal cell carcinoma and gastrointestinal stromal tumors.
Val R Adams, Markos Leggas. Clin Ther 2007
Val R Adams, Markos Leggas. Clin Ther 2007
14
Pharmacokinetics, distribution, and metabolism of [14C]sunitinib in rats, monkeys, and humans.
Bill Speed, Hai-Zhi Bu, William F Pool, Geoffrey W Peng, Ellen Y Wu, Shem Patyna, Carlo Bello, Ping Kang. Drug Metab Dispos 2012
Bill Speed, Hai-Zhi Bu, William F Pool, Geoffrey W Peng, Ellen Y Wu, Shem Patyna, Carlo Bello, Ping Kang. Drug Metab Dispos 2012
14
Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer.
Sandrine Faivre, Catherine Delbaldo, Karina Vera, Caroline Robert, Stéphanie Lozahic, Nathalie Lassau, Carlo Bello, Samuel Deprimo, Nicoletta Brega, Giorgio Massimini,[...]. J Clin Oncol 2006
Sandrine Faivre, Catherine Delbaldo, Karina Vera, Caroline Robert, Stéphanie Lozahic, Nathalie Lassau, Carlo Bello, Samuel Deprimo, Nicoletta Brega, Giorgio Massimini,[...]. J Clin Oncol 2006
14
Relationship between exposure to sunitinib and efficacy and tolerability endpoints in patients with cancer: results of a pharmacokinetic/pharmacodynamic meta-analysis.
Brett E Houk, Carlo L Bello, Bill Poland, Lee S Rosen, George D Demetri, Robert J Motzer. Cancer Chemother Pharmacol 2010
Brett E Houk, Carlo L Bello, Bill Poland, Lee S Rosen, George D Demetri, Robert J Motzer. Cancer Chemother Pharmacol 2010
14
Determination of pazopanib (GW-786034) in mouse plasma and brain tissue by liquid chromatography-tandem mass spectrometry (LC/MS-MS).
Mukul Minocha, Varun Khurana, Ashim K Mitra. J Chromatogr B Analyt Technol Biomed Life Sci 2012
Mukul Minocha, Varun Khurana, Ashim K Mitra. J Chromatogr B Analyt Technol Biomed Life Sci 2012
15
Simultaneous analysis of anticancer agents bortezomib, imatinib, nilotinib, dasatinib, erlotinib, lapatinib, sorafenib, sunitinib and vandetanib in human plasma using LC/MS/MS.
Irina Andriamanana, Ines Gana, Bénédicte Duretz, Anne Hulin. J Chromatogr B Analyt Technol Biomed Life Sci 2013
Irina Andriamanana, Ines Gana, Bénédicte Duretz, Anne Hulin. J Chromatogr B Analyt Technol Biomed Life Sci 2013
14
Development and validation of an high performance liquid chromatography-tandem mass spectrometry method for the determination of imatinib in rat tissues.
F Bianchi, E Caffarri, S Cavalli, C Lagrasta, M Musci, F Quaini, M Savi. J Pharm Biomed Anal 2013
F Bianchi, E Caffarri, S Cavalli, C Lagrasta, M Musci, F Quaini, M Savi. J Pharm Biomed Anal 2013
50
Determination of sunitinib in human plasma using liquid chromatography coupled with mass spectrometry.
Jacek Musijowski, Edyta Piórkowska, Piotr J Rudzki. J Sep Sci 2014
Jacek Musijowski, Edyta Piórkowska, Piotr J Rudzki. J Sep Sci 2014
41
11
Sunitinib: a VEGF and PDGF receptor protein kinase and angiogenesis inhibitor.
Robert Roskoski. Biochem Biophys Res Commun 2007
Robert Roskoski. Biochem Biophys Res Commun 2007
11
Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial.
George D Demetri, Allan T van Oosterom, Christopher R Garrett, Martin E Blackstein, Manisha H Shah, Jaap Verweij, Grant McArthur, Ian R Judson, Michael C Heinrich, Jeffrey A Morgan,[...]. Lancet 2006
George D Demetri, Allan T van Oosterom, Christopher R Garrett, Martin E Blackstein, Manisha H Shah, Jaap Verweij, Grant McArthur, Ian R Judson, Michael C Heinrich, Jeffrey A Morgan,[...]. Lancet 2006
11
An HPLC-UV method for the simultaneous quantification of vemurafenib and erlotinib in plasma from cancer patients.
Yi Zhen, Audrey Thomas-Schoemann, Lilia Sakji, Pascaline Boudou-Rouquette, Nicolas Dupin, Laurent Mortier, Michel Vidal, Francois Goldwasser, Benoit Blanchet. J Chromatogr B Analyt Technol Biomed Life Sci 2013
Yi Zhen, Audrey Thomas-Schoemann, Lilia Sakji, Pascaline Boudou-Rouquette, Nicolas Dupin, Laurent Mortier, Michel Vidal, Francois Goldwasser, Benoit Blanchet. J Chromatogr B Analyt Technol Biomed Life Sci 2013
14
Quantification of sunitinib and N-desethyl sunitinib in human EDTA plasma by liquid chromatography coupled with electrospray ionization tandem mass spectrometry: validation and application in routine therapeutic drug monitoring.
Nienke A G Lankheet, N Steeghs, H Rosing, J H M Schellens, J H Beijnen, A D R Huitema. Ther Drug Monit 2013
Nienke A G Lankheet, N Steeghs, H Rosing, J H M Schellens, J H Beijnen, A D R Huitema. Ther Drug Monit 2013
26
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma.
Robert J Motzer, Thomas E Hutson, Piotr Tomczak, M Dror Michaelson, Ronald M Bukowski, Olivier Rixe, Stéphane Oudard, Sylvie Negrier, Cezary Szczylik, Sindy T Kim,[...]. N Engl J Med 2007
Robert J Motzer, Thomas E Hutson, Piotr Tomczak, M Dror Michaelson, Ronald M Bukowski, Olivier Rixe, Stéphane Oudard, Sylvie Negrier, Cezary Szczylik, Sindy T Kim,[...]. N Engl J Med 2007
8
Sorafenib and sunitinib: novel targeted therapies for renal cell cancer.
Cheryl A Grandinetti, Barry R Goldspiel. Pharmacotherapy 2007
Cheryl A Grandinetti, Barry R Goldspiel. Pharmacotherapy 2007
8
Sunitinib: a multitargeted receptor tyrosine kinase inhibitor in the era of molecular cancer therapies.
Georgios S Papaetis, Kostas N Syrigos. BioDrugs 2009
Georgios S Papaetis, Kostas N Syrigos. BioDrugs 2009
8
Sunitinib malate.
Hassane Izzedine, Irina Buhaescu, Olivier Rixe, Gilbert Deray. Cancer Chemother Pharmacol 2007
Hassane Izzedine, Irina Buhaescu, Olivier Rixe, Gilbert Deray. Cancer Chemother Pharmacol 2007
8
Effect of food on the pharmacokinetics of sunitinib malate (SU11248), a multi-targeted receptor tyrosine kinase inhibitor: results from a phase I study in healthy subjects.
Carlo L Bello, Laurie Sherman, Jihao Zhou, Lev Verkh, John Smeraglia, Janessa Mount, Karen J Klamerus. Anticancer Drugs 2006
Carlo L Bello, Laurie Sherman, Jihao Zhou, Lev Verkh, John Smeraglia, Janessa Mount, Karen J Klamerus. Anticancer Drugs 2006
8
Direct analysis of biological tissue by paper spray mass spectrometry.
He Wang, Nicholas E Manicke, Qian Yang, Lingxing Zheng, Riyi Shi, R Graham Cooks, Zheng Ouyang. Anal Chem 2011
He Wang, Nicholas E Manicke, Qian Yang, Lingxing Zheng, Riyi Shi, R Graham Cooks, Zheng Ouyang. Anal Chem 2011
8
Sunitinib in patients with metastatic renal cell carcinoma.
Robert J Motzer, Brian I Rini, Ronald M Bukowski, Brendan D Curti, Daniel J George, Gary R Hudes, Bruce G Redman, Kim A Margolin, Jaime R Merchan, George Wilding,[...]. JAMA 2006
Robert J Motzer, Brian I Rini, Ronald M Bukowski, Brendan D Curti, Daniel J George, Gary R Hudes, Bruce G Redman, Kim A Margolin, Jaime R Merchan, George Wilding,[...]. JAMA 2006
8
Discovery of 5-[5-fluoro-2-oxo-1,2- dihydroindol-(3Z)-ylidenemethyl]-2,4- dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide, a novel tyrosine kinase inhibitor targeting vascular endothelial and platelet-derived growth factor receptor tyrosine kinase.
Li Sun, Chris Liang, Sheri Shirazian, Yong Zhou, Todd Miller, Jean Cui, Juri Y Fukuda, Ji-Yu Chu, Asaad Nematalla, Xueyan Wang,[...]. J Med Chem 2003
Li Sun, Chris Liang, Sheri Shirazian, Yong Zhou, Todd Miller, Jean Cui, Juri Y Fukuda, Ji-Yu Chu, Asaad Nematalla, Xueyan Wang,[...]. J Med Chem 2003
8
Individualised cancer chemotherapy: strategies and performance of prospective studies on therapeutic drug monitoring with dose adaptation: a review.
Milly E de Jonge, Alwin D R Huitema, Jan H M Schellens, Sjoerd Rodenhuis, Jos H Beijnen. Clin Pharmacokinet 2005
Milly E de Jonge, Alwin D R Huitema, Jan H M Schellens, Sjoerd Rodenhuis, Jos H Beijnen. Clin Pharmacokinet 2005
8
Differential effect of sunitinib on the distribution of temozolomide in an orthotopic glioma model.
Qingyu Zhou, James M Gallo. Neuro Oncol 2009
Qingyu Zhou, James M Gallo. Neuro Oncol 2009
8
High-performance liquid chromatographic method for the determination of sorafenib in human serum and peritoneal fluid.
Werner J Heinz, Kathrin Kahle, Annegret Helle-Beyersdorf, Diana Schirmer, Ulrike Lenker, Daniela Keller, Peter Langmann, Hartwig Klinker. Cancer Chemother Pharmacol 2011
Werner J Heinz, Kathrin Kahle, Annegret Helle-Beyersdorf, Diana Schirmer, Ulrike Lenker, Daniela Keller, Peter Langmann, Hartwig Klinker. Cancer Chemother Pharmacol 2011
10
HPLC-DAD protein kinase inhibitor analysis in human serum.
Marek Dziadosz, Rüdiger Lessig, Heidemarie Bartels. J Chromatogr B Analyt Technol Biomed Life Sci 2012
Marek Dziadosz, Rüdiger Lessig, Heidemarie Bartels. J Chromatogr B Analyt Technol Biomed Life Sci 2012
13
Quantitative determination of imatinib in human plasma with high-performance liquid chromatography and ultraviolet detection.
Masatomo Miura, Naoto Takahashi, Ken-ichi Sawada. J Chromatogr Sci 2011
Masatomo Miura, Naoto Takahashi, Ken-ichi Sawada. J Chromatogr Sci 2011
11
High-performance liquid chromatography with solid-phase extraction for the quantitative determination of nilotinib in human plasma.
Masatomo Miura, Naoto Takahashi, Ken-ichi Sawada. Biomed Chromatogr 2010
Masatomo Miura, Naoto Takahashi, Ken-ichi Sawada. Biomed Chromatogr 2010
12
Simultaneous quantification of ruxolitinib and nilotinib in rat plasma by LC-MS/MS: application to a pharmacokinetic study.
Sridhar Veeraraghavan, Satheeshmanikandan Thappali, Srikant Viswanadha, Sandhyarani Chennupati, Santhoshkumar Nalla, Manikantakumar Golla, Swaroopkumar Vakkalanka, Manivannan Rangasamy. J Pharm Biomed Anal 2014
Sridhar Veeraraghavan, Satheeshmanikandan Thappali, Srikant Viswanadha, Sandhyarani Chennupati, Santhoshkumar Nalla, Manikantakumar Golla, Swaroopkumar Vakkalanka, Manivannan Rangasamy. J Pharm Biomed Anal 2014
25
A validated LC-MS/MS assay for the simultaneous determination of the anti-leukemic agent dasatinib and two pharmacologically active metabolites in human plasma: application to a clinical pharmacokinetic study.
Michael T Furlong, Shruti Agrawal, Dara Hawthorne, Michael Lago, Steve Unger, Linda Krueger, Bruce Stouffer. J Pharm Biomed Anal 2012
Michael T Furlong, Shruti Agrawal, Dara Hawthorne, Michael Lago, Steve Unger, Linda Krueger, Bruce Stouffer. J Pharm Biomed Anal 2012
15
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.